Citi raised the firm’s price target on iRhythm (IRTC) to $242 from $205 and keeps a Buy rating on the shares. The company reported a “beat-and-raise” Q3, says Citi, which sees additional upside in the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IRTC:
- iRhythm price target raised to $212 from $193 at Canaccord
- Irhythm Technologies: Strong Q3 Performance and Positive Outlook Justify Buy Rating
- Irhythm Technologies: Strong Performance and Promising Growth Potential Justify Buy Rating
- iRhythm Technologies: Strong Growth and Strategic Initiatives Justify Buy Rating
- iRhythm Technologies Reports Strong Q3 2025 Growth